Option Care Health (NASDAQ:OPCH) Sees Large Volume Increase – Should You Buy?

Shares of Option Care Health, Inc. (NASDAQ:OPCH) saw an uptick in trading volume on Friday . 3,834,392 shares were traded during trading, an increase of 164% from the previous session’s volume of 1,450,343 shares.The stock last traded at $24.03 and had previously closed at $23.04.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on OPCH. Barrington Research decreased their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their target price for the company from $38.00 to $26.00 in a research report on Thursday. Truist Financial dropped their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $43.00 to $29.00 in a report on Wednesday. Finally, JMP Securities boosted their target price on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $31.60.

Option Care Health Stock Up 4.6 %

The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.36 and a current ratio of 1.73. The stock’s fifty day simple moving average is $30.49 and its two-hundred day simple moving average is $29.91. The company has a market capitalization of $4.10 billion, a price-to-earnings ratio of 20.26, a P/E/G ratio of 1.74 and a beta of 1.32.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Wednesday, October 30th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.22 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.23 EPS for the current year.

Insider Activity

In related news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Massachusetts Financial Services Co. MA acquired a new position in Option Care Health during the second quarter valued at $68,003,000. Magnetar Financial LLC increased its holdings in shares of Option Care Health by 124.8% in the 2nd quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock valued at $68,750,000 after purchasing an additional 1,377,929 shares during the period. Duquesne Family Office LLC increased its holdings in shares of Option Care Health by 172.8% in the 2nd quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock valued at $51,849,000 after purchasing an additional 1,185,613 shares during the period. Hood River Capital Management LLC lifted its position in shares of Option Care Health by 77.2% in the second quarter. Hood River Capital Management LLC now owns 1,729,029 shares of the company’s stock worth $47,894,000 after purchasing an additional 753,208 shares in the last quarter. Finally, Westfield Capital Management Co. LP boosted its holdings in shares of Option Care Health by 15.4% during the first quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock worth $173,448,000 after purchasing an additional 688,653 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.